Diletti, Roberto <br/><br/>
ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.  [electronic resource] 

 -  American heart journal  Nov 2012 
 - 654-63 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2012.08.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorbable Implants--adverse effects<br/>Adult<br/>Aged<br/>Aspirin--administration & dosage<br/>Coronary Angiography<br/>Coronary Artery Disease--complications<br/>Coronary Thrombosis--etiology<br/>Drug-Eluting Stents--adverse effects<br/>Europe<br/>Everolimus<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Myocardial Ischemia--drug therapy<br/>New Zealand<br/>Piperazines--administration & dosage<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Prasugrel Hydrochloride<br/>Research Design<br/>Sample Size<br/>Single-Blind Method<br/>Sirolimus--analogs & derivatives<br/>Spectroscopy, Near-Infrared<br/>Thiophenes--administration & dosage<br/>Tissue Scaffolds--adverse effects<br/>Tomography, X-Ray Computed<br/>Ultrasonography, Interventional